BioRestorative Therapies’ Stockholders Approve Institutional Investor Agreement and Exchange Agreements

Ads

You May Also Like

Inovio’s Zika Vaccine Selected As 2016 Technology Breakthrough

PLYMOUTH MEETING, Pa., Sept. 12, 2016 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today ...

OSE Immunotherapeutics Reports First-Half 2018 Results and Provides a Corporate Update

Key Highlights: Entered into a global immuno-oncology agreement in April 2018 with Boehringer Ingelheim ...